Home » Newsletters » BioWorld Science

BioWorld Science

June 21, 2022

View Archived Issues

CAMLG gene mutation c.633+4A>G causes a novel neurological phenotype

Medulloblastoma murine model dissects its poorly known biology

Variant in ABO blood group gene associated with long COVID

Hangzhou Polymed Biopharmaceuticals identifies new G12C mutant KRAS inhibitors

New phosphodiesterase PDE4B1 inhibitors discovered at Reistone Biopharma

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group patent vasopressin receptor antagonists

Peking University describes radiation-activated tetravalent platinum complex

New cyclin-dependent kinase inhibitors divulged by Allorion Therapeutics

Ovarian fibrosis-mediated ovulation failure is reversible: study

Study identifies novel genes causing male infertility

New mouse model displays stable hyperglycemia without age-related morbidity

IND clearance for anti-CD20 armed allogeneic gamma delta T-cell therapy ACE-1831 for NHL

miR-662 revealed as a metastatis-to-bone marker in breast cancer

Use of [177Lu]Lu-CCZ01158 shows promise for the treatment of human melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.